Paclitaxel-Avelumab for Angiosarcoma

NCT03512834 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Angiosarcoma Metastatic

Interventions

DRUG: Avelumab
DRUG: Paclitaxel

Sponsor

Sung Yong Oh

Collaborators

[object Object]